JPMorgan Chase & Co. grew its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 63.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 630,644 shares of the business services provider’s stock after buying an additional 245,086 shares during the period. JPMorgan Chase & Co. owned 1.24% of Exponent worth $72,701,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently modified their holdings of EXPO. Inspire Advisors LLC raised its position in Exponent by 1.3% in the second quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider’s stock valued at $724,000 after purchasing an additional 98 shares during the period. Caprock Group LLC boosted its holdings in Exponent by 4.2% in the second quarter. Caprock Group LLC now owns 3,296 shares of the business services provider’s stock valued at $314,000 after purchasing an additional 134 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Exponent by 11.0% during the 2nd quarter. Parkside Financial Bank & Trust now owns 2,008 shares of the business services provider’s stock worth $191,000 after buying an additional 199 shares during the last quarter. Mitchell & Pahl Private Wealth LLC raised its stake in Exponent by 3.7% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 5,961 shares of the business services provider’s stock worth $687,000 after acquiring an additional 214 shares in the last quarter. Finally, Westside Investment Management Inc. purchased a new position in shares of Exponent during the third quarter worth about $26,000. 92.37% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Exponent
In other news, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now owns 5,871 shares of the company’s stock, valued at $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Paul R. Johnston sold 1,300 shares of the firm’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $95.03, for a total transaction of $123,539.00. Following the completion of the sale, the director now owns 59,406 shares of the company’s stock, valued at approximately $5,645,352.18. The trade was a 2.14 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,339 shares of company stock worth $3,103,065. Company insiders own 2.10% of the company’s stock.
Exponent Stock Up 1.1 %
Exponent Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Friday, December 6th were issued a $0.28 dividend. The ex-dividend date was Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.26%. Exponent’s payout ratio is 54.11%.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories
- Five stocks we like better than Exponent
- Pros And Cons Of Monthly Dividend Stocks
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- How to invest in marijuana stocks in 7 stepsĀ
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.